Back

Electra Therapeutics sets terms for 21.7 million-share Nasdaq IPO at $14-$16

Verifying
  • Electra Therapeutics set terms for a 21.7 million-share Nasdaq offering.
  • $14 to $16 per share implies as much as $347 million in proceeds.
  • Ipsoprubart’s SURPASS study is enrolling adult and paediatric patients in the United States and Europe.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.